ImpediMed Appoints Richard Valencia as MD and CEO
- ImpediMed (IPD) appoints Richard Valencia as its Managing Director and CEO, effective December 1
- Current interim CEO David Anderson will continue to support the company to help ensure a smooth transition of leadership
- Mr Valencia has 30 years of leadership experience in the healthcare and technology industries and has held executive positions in companies such as WaveForm Diabetes
- He will receive a salary of US$450,000 per annum with no fixed term to his position
- Shares in the company are down 1.08 per cent, trading at 9.2 cents at 3:08 pm AEDT
